Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SCYNEXIS Inc SCYX

Healthcare
SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. It develops antifungal platform fungerps, a novel class of antifungal agents called triterpenoids, that are structurally distinct glucan synthase inhibitors and have generally shown in vitro and in vivo activity against a range of human fungal pathogens,... see more

Recent & Breaking News (NDAQ:SCYX)

Scynexis Deadline Reminder

Newsfile January 7, 2024

Final Deadline Alert: Bronstein, Gewirtz & Grossman LLC Reminds Scynexis, Inc. (SCYX) Investors with Substantial Losses to Contact the Firm!

Accesswire January 7, 2024

SCYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that SCYNEXIS, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Newsfile January 7, 2024

SCYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that SCYNEXIS, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

PR Newswire January 7, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SCYNEXIS, Inc. - SCYX

PR Newswire January 6, 2024

Scynexis 48 Hour Deadline Alert

Newsfile January 6, 2024

SCYX DEADLINE ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX

Newsfile January 5, 2024

DEADLINE MONDAY ALERT: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the Firm

Newsfile January 5, 2024

SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 11th Advances Against Aspergillosis and Mucormycosis Conference, January 25 - 27, in Milan, Italy

GlobeNewswire January 5, 2024

Upcoming SCYX Deadline: Bronstein, Gewirtz & Grossman LLC Reminds Scynexis, Inc. Investors with Substantial Losses to Actively Participate in the Class Action Lawsuit!

Accesswire January 5, 2024

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the Firm

Accesswire January 5, 2024

SCYX DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX

TheNewsWire January 4, 2024

DEADLINE NEXT WEEK: Berger Montague Advises SCYNEXIS, Inc. (SCYX) Investors to Contact the Firm Before January 8, 2024

Newsfile January 4, 2024

SCYX Investors Have Opportunity to Lead SCYNEXIS, Inc. Securities Fraud Lawsuit

PR Newswire January 4, 2024

MONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the Firm

Newsfile January 4, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SCYNEXIS, Inc. - SCYX

Accesswire January 4, 2024

SCYNEXIS INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options

PR Newswire January 4, 2024

Upcoming SCYX Deadline: Bronstein, Gewirtz & Grossman LLC Reminds Scynexis, Inc. Investors with Substantial Losses to Actively Participate in the Class Action Lawsuit!

Accesswire January 4, 2024

SCYX DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX

Newsfile January 3, 2024

SCYX Investors Have Opportunity to Lead SCYNEXIS, Inc. Securities Fraud Lawsuit

PR Newswire January 3, 2024